PAUL STEVEN M

ALNY

PAUL STEVEN M serves as an insider at Alnylam Pharmaceuticals, Inc. (ALNY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1.03M

Total Sells

1 trades

$2.56M

Net Position

Net Seller

$1.53M

Companies Traded

RAPP, ALNY

Active Period

Apr 2022 – Sep 2025

2 total trades

Most Recent

Buy RAPP

Sep 15, 2025 · $1.03M

PAUL STEVEN M's Insider Trading at Alnylam Pharmaceuticals, Inc. (ALNY)

Buys

0 · $0.00

Sells

1 · $2.56M

Total Shares Bought

Total Shares Sold

15,000

ALNY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 1, 2022	Sell	15,000	$170.69	$2.56M	0

PAUL STEVEN M's Insider Trading at Rapport Therapeutics, Inc. Common Stock (RAPP)

Buys

1 · $1.03M

Sells

0 · $0.00

Total Shares Bought

41,666

Total Shares Sold

RAPP Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 15, 2025	Buy	41,666	$24.65	$1.03M	41,666

Related Insiders

Krishnaswamy Yeleswaram

officer: Chief Development Officer

RAPPSell · Apr 21, 2026

Third Rock Ventures V, L.P.

10 percent owner

RAPPSell · Apr 21, 2026

Melissa McLaughlin

officer: Chief Human Resources Officer

ALNYSell · Apr 7, 2026

Cheryl Gault

officer: Chief Operating Officer

RAPPSell · Mar 31, 2026

Pushkal Garg

officer: EVP Chief R&D

ALNYSell · Mar 6, 2026

Jeffrey V. Poulton

officer: EVP, Chief Financial Officer

ALNYSell · Mar 6, 2026

Tolga Tanguler

officer: EVP, Chief Commercial Officer

ALNYSell · Mar 6, 2026

Yvonne Greenstreet

director, officer: Chief Executive Officer

ALNYSell · Mar 6, 2026

Explore More Insider Trading Data

ALNY Insider Trading Activity

View all insider trades at Alnylam Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity